ReviewCancers2018

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAF

Antoni Xavier Torres-Collado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.